The PAM50 is robust for use in epidemiologic studies and should be considered when archived tumor tissues are available.
No takes yet. Share an insight, caveat, or question.
Caan et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: